How much is your DNA worth? As millions of people pay for home tests to check on ancestry or health risks, genetic data is becoming an increasingly valuable resource for drugmakers, triggering a race to create a DNA marketplace. GlaxoSmithKline’s decision to invest $300 million in 23andMe and forge ...
The post Cashing in on DNA: race on to unlock value in genetic data appeared first on Raw Story.
CONTINUE READING >>>